(3R,9R,10R)-Panaxytriol: a molecular-based nutraceutical with possible application to cancer prevention and treatment

Tetrahedron Letters

Volumn 49, Issue 50, 2008, Pages 7178-7179

  Ng, Fay ^a   Yun, Heedong ^a   Lei, Xiaoguang ^a   Danishefsky, Samuel J ^a,b   Fahey, Jed ^c   Stephenson, Katherine ^c   Flexner, Charles ^c   Lee, Lawrence ^c  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GINSENG EXTRACT; NATURAL PRODUCT; NUTRACEUTICAL; PANAXYTRIOL; PROTOPANAXATRIOL; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE (PHOSPHATE) DEHYDROGENASE (QUINONE); UNCLASSIFIED DRUG;

ANIMAL CELL; ANTINEOPLASTIC ACTIVITY; ARTICLE; BREAST CARCINOMA; CANCER PREVENTION; CYTOTOXICITY; DETOXIFICATION; DRUG MECHANISM; ENZYME INDUCTION; GINSENG; HUMAN; KOREA; LYMPHOMA; MEDICINAL PLANT; MELANOMA CELL; MOUSE; NONHUMAN; PHYTOCHEMISTRY; STOMACH CARCINOMA; STRUCTURE ACTIVITY RELATION; SYNTHESIS; TRADITIONAL MEDICINE;

PANAX GINSENG;

EID: 54449089712     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tetlet.2008.09.169     Document Type: Article

References (20)

1. www.nlm.nih.gov for ginseng related literature.
2. Helms S. Altern. Med. Rev. 9 (2004) 259
3. Saito T., Matsunaga H., Yamamoto H., Nagumo F., Fujito H., Mori M., and Katano M. Biol. Pharm. Bull. 17 (1994) 798
4. Kitagawa I., Yoshikawa M., Yoshihara M., Hayashi T., and Taniyama T. Yakugaku Zasshi 103 (1983) 612
5. Saita T., Katano M., Matsunaga H., Kouno I., Fujito H., and Mori M. Biol. Pharm. Bull. 18 (1995) 933
6. Kim J.Y., Lee K.W., Kim S.H., Wee J.J., Kim Y.S., and Lee H.J. Planta Med. 68 (1992) 119
7. Matsunaga H., Saita T., Naguo F., Mori M., and Katano M. Cancer Chemother. Pharmacol. 35 (1995) 291
8. Katano M., Yamamoto H., Matsunaga H., Mori M., Takata K., and Nakamura M. Gan to Kagaku Ryoho 17 (1990) 1045
9. Yun H., and Danishefsky S.J. J. Org. Chem. 68 (2003) 4519
10. For other syntheses of panaxytriol see:. Cho E.J., and Lee D. Org. Lett. 10 (2008) 257
11. Yadav J.S., and Maiti A. Tetrahedron 58 (2002) 4955
12. Mayer S.F., Steinreiber A., Orru R.V.A., and Faber K. J. Org. Chem. 67 (2002) 9115
13. Lu W., Zheng G.R., and Cai J.C. Synlett (1998) 737
14. Satoh M., Takeuchi N., and Fujimoto Y. Chem. Pharm. Bull. 45 (1997) 1114
15. Yun H., Chou T.-C., Dong H., Tian Y., Li Y.-m., and Danishefsky S.J. J. Org. Chem. 70 (2005) 10375
16. Talalay P. BioFactors 12 (2000) 5
17. Prochaska H.J., and Santamaria A.B. Anal. Biochem. 169 (1988) 328
18. An independent study from the laboratories of Dr. Dalibor Sames at Columbia University supports the phase 2 enzyme induction mode of action of panaxytriol: Halim, M.; Yee, D.; Sames, D. J. Am. Chem. Soc. 2008.
19. Unpublished results in collaboration with Dr. Dalibor Sames of Columbia University.
20. Wilson R.M., and Danishefsky S.J. J. Org. Chem. 71 (2006) 8329